ABBV 1Q19 HCV sales=$815M—(-5% QoQ)—inline with 2019 guidance of $3.3B: https://finance.yahoo.com/news/abbvie-reports-first-quarter-2019-114200769.html US and ex-US HCV sales were $403M (flat QoQ) and $412M (-11% QoQ), respectively.